120 related articles for article (PubMed ID: 6090353)
21. In vitro evaluation of some latent radioprotective compounds.
Vos O; Budke L; Grant GA
Int J Radiat Biol Relat Stud Phys Chem Med; 1976 Nov; 30(5):433-48. PubMed ID: 187547
[TBL] [Abstract][Full Text] [Related]
22. Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection.
Smoluk GD; Fahey RC; Calabro-Jones PM; Aguilera JA; Ward JF
Cancer Res; 1988 Jul; 48(13):3641-7. PubMed ID: 2837320
[TBL] [Abstract][Full Text] [Related]
23. WR-2721, its derivatives and their radioprotective effects on mammalian cells in culture.
Mori T; Watanabe M; Horikawa M; Nikaido P; Kimura H; Aoyama T; Sugahara T
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Jul; 44(1):41-53. PubMed ID: 6305861
[TBL] [Abstract][Full Text] [Related]
24. Metabolic pathways of WR-2721 (ethyol, amifostine) in the BALB/c mouse.
Shaw LM; Bonner HS; Brown DQ
Drug Metab Dispos; 1994; 22(6):895-902. PubMed ID: 7895607
[TBL] [Abstract][Full Text] [Related]
25. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).
Khodarev NN; Kataoka Y; Murley JS; Weichselbaum RR; Grdina DJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):553-63. PubMed ID: 15380592
[TBL] [Abstract][Full Text] [Related]
26. Feasibility study of the pharmacology of local application of amifostine (WR-2721) to the buccal mucosa in guinea pigs.
Li C; Wang S; Huang T; Chen N; Ou M
Pharmacology; 2013; 91(5-6):281-6. PubMed ID: 23736649
[TBL] [Abstract][Full Text] [Related]
27. The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron.
Yu Z; Eaton JW; Persson HL
Redox Rep; 2003; 8(6):347-55. PubMed ID: 14980067
[TBL] [Abstract][Full Text] [Related]
28. Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug.
Calabro-Jones PM; Aguilera JA; Ward JF; Smoluk GD; Fahey RC
Cancer Res; 1988 Jul; 48(13):3634-40. PubMed ID: 2837319
[TBL] [Abstract][Full Text] [Related]
29. Radiation protection of rat parenchymal hepatocytes with S-2-(3-aminopropylamino)ethylphosphorothioic acid.
Jirtle RL; Pierce LJ; Crocker IR; Strom SC
Radiother Oncol; 1985 Nov; 4(3):231-7. PubMed ID: 3001838
[TBL] [Abstract][Full Text] [Related]
30. The effect of the radioprotector WR-2721 and WR-1065 on mitochondrial lipid peroxidation.
Tretter L; Rónai E; Szabados G; Hermann R; Andó A; Horváth I
Int J Radiat Biol; 1990 Mar; 57(3):467-78. PubMed ID: 1968940
[TBL] [Abstract][Full Text] [Related]
31. Radioprotection of mouse jejunum by WR-2721 and WR-1065: effects on DNA strand-break induction and rejoining.
Murray D; Milas L; Meyn RE
Radiat Res; 1988 May; 114(2):268-80. PubMed ID: 2836883
[TBL] [Abstract][Full Text] [Related]
32. Human pharmacokinetics of WR-2721.
Shaw LM; Turrisi AT; Glover DJ; Bonner HS; Norfleet AL; Weiler C; Kligerman MM
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1501-4. PubMed ID: 3019968
[TBL] [Abstract][Full Text] [Related]
33. Effect of the radioprotective drugs MEA, DMSO, and WR-2721 on tumor control and skin tolerance in the rat.
Moulder JE; Lo PS; Fischer JJ
Cancer Treat Rep; 1977 Aug; 61(5):825-33. PubMed ID: 196752
[TBL] [Abstract][Full Text] [Related]
34. Cystine depletion by WR-1065 in cystinotic cells. Mechanism of action.
Butler JD; Gahl WA; Tietze F
Biochem Pharmacol; 1985 Jun; 34(12):2179-85. PubMed ID: 2988568
[TBL] [Abstract][Full Text] [Related]
35. Chromosome protection by WR-2721 and MPG-single and combination treatments.
Thomas B; Devi PU
Strahlenther Onkol; 1987 Dec; 163(12):807-10. PubMed ID: 2827332
[TBL] [Abstract][Full Text] [Related]
36. Opposite effects of WR-2721 and WR-1065 on radiation-induced hypothermia: possible correlation with oxygen uptake.
Kandasamy SB; Kumar KS; Hunt WA; Weiss JF
Radiat Res; 1988 May; 114(2):240-7. PubMed ID: 2836882
[TBL] [Abstract][Full Text] [Related]
37. Clearance of S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913) in rats.
Lam TT; Liu D; Brody MA; Chu R; Tso MO
Exp Eye Res; 1991 Jun; 52(6):661-7. PubMed ID: 1649765
[TBL] [Abstract][Full Text] [Related]
38. Modification of WR-2721 toxicity and radioprotection by an inhibitor of alkaline phosphatase.
Brown DQ; Shaw LM; Pittock JW; Mann DJ; Hardiman J; Pogach R; Gold J
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1491-3. PubMed ID: 3019966
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of the radioprotective effects of cysteamine, WR-2721, and WR-1065 in cultured human cells.
Purdie JW
Radiat Res; 1979 Feb; 77(2):303-11. PubMed ID: 220662
[No Abstract] [Full Text] [Related]
40. Protection of cultured mammalian cells by S-2-(3-aminopropylamino)ethylphosphorothioic acid(WR-2721).
Antoku S
Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1481-5. PubMed ID: 6313559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
